High quality products to support Pathologists and Biological and Environmental Scientists
Control for SARS-CoV-2 Serologic Assay
$250.00Mixture of recombinant humanized IgG and IgM monoclonal antibodies directed against the NP protein of SARS-CoV-2 virus. This serves as an excellent and harmless positive control for Anti-SARS-CoV-2 immunoassays.
SARS-CoV-2 Antibody Assay
$150.00This is an Antibody Serologic Assay (SCSA) for SARS-CoV-2.
This test has not been reviewed by the FDA.
The SARS-CoV-2 Antibody rapid test is a lateral flow chromatographic immunoassay for the qualitative detection of IgM/IgG anti-SARS CoV-2 antibody which may be found in samples such as serum, plasma, whole blood or cell culture media. This product is suitable for screening for the presence of SARS-CoV-2 reactive antibody in a Research Use Only Fashion.
Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.
Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
SARS-CoV-2 Antigen Assay (SCAA)
$125.0025 tests per kit.
Used for in vitro qualitative detection of SARS-CoV-2 antigens in human swabs samples (Nasopharyngeal swab and oropharyngeal swab). It can only be used as a supplementary test indicator for suspected cases with negative PCR test of SARS-CoV-2 or used in conjunction with PCR testing in the diagnosis of suspected cases.
COVID-19 Real-Time PCR assay EUA (USA)
$1,321.04Product Features
- • FOR US ONLY
- • Rapid detection and exclusive to the COVID-19 strain
- • Does not detect other related coronavirus strains
- • High priming efficiency
- • Accurate controls to confirm extraction, and assay validity
- • Lyophilised components for ambient shipping
- • Highly specific detection profile
This test has been authorized by FDA under an EUA for use by authorized laboratories.
Coronavirus (COVID-19, Strain 2019-nCoV)
$1,321.04Product Features
- • Exceptional value for money
- • Rapid detection of 2019-nCoV
- • Positive copy number standard curve for quantification
- • Highly specific detection profile
- • High priming efficiency
- • Broad dynamic detection range (>6 logs)
- • Sensitive to < 100 copies of target
- • Accurate controls to confirm findings
exsig® COVID-19 Direct
$2,103.08A total workflow solution with all reagents and components provided from start to finish.
- • Total workflow solution
- • All reagents and components provided from start to finish
- • Rapid protocol with fewer handling steps
- • For use with dry swabs
- • Viral inactivation; Preparation, Amplification, Diagnosis
- • Total chemistry optimisation
- • Low shipping costs with ambient shipping
- • Includes our genesig® Real-Time PCR Coronavirus COVID-19 (CE IVD)
SNPsig® SARS-CoV-2 (20I/501Y.V1) Identification Kit
$1,500.00- • For the detection of the SARS-CoV-2 (20I/501Y.V1 UK)
- • Rapid detection of specific detection profiles
- • High priming efficiency
- • Sensitive to < 100 copies of target
- • Positive copy number standard curve for quantification
- • Accurate controls to confirm findings
- • 96 reactions, includes master mix
SNPsig® SARS-CoV-2 (N501Y) Identification Kit
$1,500.00- • For the detection of the SARS-CoV-2 variants with the N501Y mutation (UK, South Africa and Brazil)
- • Rapid detection of specific detection profiles
- • High priming efficiency
- • Sensitive to < 100 copies of target
- • Positive copy number standard curve for quantification
- • Accurate controls to confirm findings
- • 96 reactions, includes master mix